Skip to main content

Find Clinical Trials

Home
Conditions
Metastatic Cancer

Clinical trial condition

Metastatic Cancer

Explore clinical trials studying Metastatic Cancer. Study availability and eligibility vary by location and protocol.

430 public trials 83 recruiting studies

Refine in advanced search Browse all conditions

Metastatic Cancer trial results

Not Yet Recruiting

A Phase 1/2 Study of Personalized PSMA Radiopharmaceutical Therapy

NCT05896371

Conditions: Cancer, Genital Diseases, Genital Diseases, Male, +15 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Lvosidenib (AK112) Combined With CapeOX and Radiotherapy in Patients With Unresectable Metastatic MSS-type Colorectal Cancer

NCT06593548

Conditions: CRC, MSS, Metastatic Cancer, +5 more
Locations: Xinxiang Li Shanghai, Shanghai Municipality, China

View Trial Details

Completed

Study of Avutometinib (VS-6766) + Adagrasib in KRAS G12C NSCLC Patients

NCT05375994

Conditions: Advanced Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +17 more
Locations: UCSF Thoracic Oncology San Francisco, California, United States

University of Colorado Hospital Anschutz Cancer Pavllion Aurora, Colorado, United States

Mayo Clinic Cancer Center Jacksonville, Florida, United States

Mayo Clinic Cancer Center Rochester, Minnesota, United States

View Trial Details

Completed

Durvalumab (MEDI4736) With Cetuximab in Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

NCT03691714

Conditions: Head and Neck Cancer, Head and Neck Neoplasms, Metastatic Cancer, +7 more
Locations: UC Health Cincinnati, Ohio, United States

View Trial Details

Completed

Medico-economic Evaluation Comparing the Impact of the New Fixed-dose Nivolumab Regimen With the Old mg/kg Regimen in the Management of Patients With Metastatic Cancer

NCT05380336

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +23 more
Locations: CHU de Nantes Nantes, France

View Trial Details

Completed

Predicting Disease Progression and/or Recurrence in Cancer

NCT04776837

Conditions: Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +30 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Single Dose Radiotherapy (SDRT) in Oligometatstasis Ablation

NCT03543696

Conditions: Metastatic Cancer, Neoplasm Metastasis, Neoplasms, +3 more
Locations: Champalimaud Centre for the Unknown Lisbon, Lisbon District, Portugal

View Trial Details

Completed

Study of Cabozantinib Plus TAS102 in mCRC as Salvage Therapy

NCT04868773

Conditions: CRC, Colonic Diseases, Colorectal Cancer, +16 more
Locations: Chao Family Comprehensive Cancer Center, University of California, Irvine Orange, California, United States

View Trial Details

Completed

Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies

NCT03881488

Conditions: Adenoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +32 more
Locations: Ocala Oncology Center Ocala, Florida, United States

Hematology Oncology Associates Of The Treasure Coast Port Saint Lucie, Florida, United States

Massachusetts General Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Sunitinib in Treating Patients With Kidney Cancer That Has Spread to the Brain

NCT00814021

Conditions: Adenocarcinoma, Brain Diseases, Brain Neoplasms, +25 more
Locations: Institut Claudius Regaud Toulouse, France

View Trial Details